Global Longlife Hospital and Research Ltd Financial Ratios
GLHRL · Healthcare · Current price ₹12.39
P/E ratio
65.2x
P/B ratio
0.5x
ROE
-6.8%
ROCE
-13.7%
Debt / Equity
0.00
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 65.2x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -6.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -13.7% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Global Longlife Hospital and Research Ltd's latest numbers.
Global Longlife Hospital and Research Ltd profitability
Global Longlife Hospital and Research Ltd generates a return on equity of -6.8% and a return on capital employed of -13.7%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of 65.2x, Global Longlife Hospital and Research Ltd is conservatively financed. Our overall business-quality score for the company is 3.1 / 10.
Understand the ratios
More on Global Longlife Hospital and Research Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.